<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02647593</url>
  </required_header>
  <id_info>
    <org_study_id>3-2012-0165</org_study_id>
    <nct_id>NCT02647593</nct_id>
  </id_info>
  <brief_title>The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis</brief_title>
  <official_title>The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis Showing the High Level of Aminotransferase and the Establishment of New Nomenclature ; Gallstone Hepatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gangnam Severance Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laboratory change induced by common bile duct (CBD) stone is in general observed as the&#xD;
      higher elevation of alkaline phosphatase (ALP) and gamma-glutamyl transpeptideas (É¤-GT), in&#xD;
      comparison to those of aspartate aminotransferase (AST) and alanine aminotransferase (ALT).&#xD;
      However, some patients with CBD stone show the marked increased level of aminotransferase,&#xD;
      which sometimes leads to misdiagnose those as liver disease caused by viral hepatitis,&#xD;
      ischemia, and drug toxicity. The aim of this study is to investigate the clinicopathologic&#xD;
      features of patients with CBD stones with the high level of aminotransferase in serum.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2, 2012</start_date>
  <completion_date type="Actual">October 1, 2013</completion_date>
  <primary_completion_date type="Actual">October 1, 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>clinicopathologic features of patients with CBD stones with the high level of aminotransferase</measure>
    <time_frame>1year</time_frame>
    <description>lab finding, radiologic images, and findings under ERCP such as CBD diameter, CBD stone diameter, CBD stone number, periampullary diverticulum.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">44</enrollment>
  <condition>Choledocholithiasis</condition>
  <arm_group>
    <arm_group_label>gallstone hepatitis group,</arm_group_label>
    <description>gallstone hepatitis group (Among patients diagnosed as CBD stone who displayed above 400 IU/L of aminotransferase without cholangitis),</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>control group (Among patients diagnosed as CBD stone who showed the normal value of aminotransferase)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        &quot;Patients have been diagnosed as CBD stone under endoscopic retrograde&#xD;
        cholangiopancreatography (ERCP). Among patients, patients who displayed above 400 IU/L of&#xD;
        aminotransferase without cholangitis (gallstone hepatitis group) and patients who showed&#xD;
        the normal value of aminotransferase (control group) were enrolled in this study. We&#xD;
        estimated two groups by comparing clinical features, lab finding, radiologic images, and&#xD;
        findings under ERCP such as CBD diameter, CBD stone diameter, CBD stone number,&#xD;
        periampullary diverticulum.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. patients were diagnosed with CBD stone under endoscopic retrograde&#xD;
             cholangiopancreatography (ERCP)&#xD;
&#xD;
          2. patients showing above 400 IU/L of aminotransferase when at the first admitted into&#xD;
             hospital and the control groups is the patients displaying normal AST and ALT.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. underlying hepatobiliary disease 2. alcoholics 3. cholangitis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 4, 2016</study_first_submitted>
  <study_first_submitted_qc>January 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2016</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gangnam Severance Hospital</investigator_affiliation>
    <investigator_full_name>Dong Ki Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangitis</mesh_term>
    <mesh_term>Choledocholithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

